Genetics Generation Advancement Corp. (GENETICS GENERATION ADVANCEMENT) aksje
4160.TWO
StengtGENETICS GENERATION ADVANCEMENT
Market Cap
$1,086,296,576
Om Genetics Generation Advancement Corp. (GENETICS GENERATION ADVANCEMENT) aksje
Genetics Generation Advancement Corp. provides genetic testing, molecular and science diagnostics, biotechnology, precision health, and digital innovation services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research services. It also provides bioinformatic, materials sciences, research and development management, enterprise quality management, process production operation, and e-submission products. The company was formerly known as Genesis Genetics Asia Corp. and changed its name to Genetics Generation Advancement Corp. in February 2016. Genetics Generation Advancement Corp. was founded in 2008 and is based in Taipei City, Taiwan.
Selskapsinformasjon
11494 Taipei, Taiwan
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.